Table I.

Associations between STMN1, E-Cad and VIM expression and clinicopathological characteristics of GC.

		STMN1			E-Cad			VIM
Variables	Cases (n)	Positive	Negative	P-value	Positive	Negative	P-value	Positive	Negative	P-value
Sex	167	106	61	0.311	48	119	0.184	62	105	0.383
Male	120	79	41		31	89		47	73
Female	47	27	20		17	30		15	32
Age (years)				0.406			0.557			0.731
<60	86	52	34		23	63		33	53
≥60	81	54	27		25	56		29	52
Tumor size (cm)				0.694			0.271			0.653
<5	69	45	24		23	46		27	42
≥5	98	61	37		25	73		35	63
Histological differentiation				0.061			0.014a			0.408
Well/moderate	41	21	20		18	23		13	28
Poor/undifferentiation	126	85	41		30	96		49	77
Lauren's classification				0.037a			0.017			0.581
Intestinal type	47	24	23		18	29		19	28
Diffuse type	120	82	38		30	80		43	77
Serosal invasion				0.019a			0.007b			0.534
Negative	31	14	17		15	16		10	21
Positive	136	92	44		33	103		52	84
Lymph node metastasis				0.005b			0.0001c			0.0001c
N0	42	19	23		21	21		16	73
N (+)	125	87	38		27	98		46	32
TNM stage				0.008b			0.0001c			0.039a
I+II	48	23	25		24	24		12	36
III	119	83	36		24	95		50	69

^aP<0.05

^bP<0.01

^cP<0.0001. STMN1, Stathmin1; E-Cad, E-cadherin; VIM, vimentin; GC, gastric cancer; TNM, tumor-node-metastasis.